EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Inflammatory bowel disease genomics, transcriptomics, proteomics and metagenomics meet artificial intelligence

Anna Lucia Cannarozzi, Anna Latiano iD, Luca Massimino, Fabrizio Bossa, Francesco Giuliani, Matteo Riva iD, Federica Ungaro iD, Maria Guerra, Anna Laura Di Brina, Giuseppe Biscaglia, Francesca Tavano, Sonia Carparelli iD und 4 weitere

United European Gastroenterology Journal · 2024-12 · 12 (10) · 1461-1480

DOI: 10.1002/ueg2.12655 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift United European Gastroenterology Journal, online erschienen am 31.08.2024. Verfasst von Anna Lucia Cannarozzi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Endoscopy, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. Hauptthemen laut MEDLINE: Artificial Intelligence, Inflammatory Bowel Diseases, Metagenomics, Proteomics. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Italian Next Generation Eu Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Various extrinsic and intrinsic factors such as drug exposures, antibiotic treatments, smoking, lifestyle, genetics, immune responses, and the gut microbiome characterize ulcerative colitis and Crohn's disease, collectively called inflammatory bowel disease (IBD). All these factors contribute to the complexity and heterogeneity of the disease etiology and pathogenesis leading to major challenges for the scientific community in improving management, medical treatments, genetic risk, and exposome impact. Understanding the interaction(s) among these factors and their effects on the immune system in IBD patients has prompted advances in multi‐omics research, the development of new tools as part of system biology, and more recently, artificial intelligence (AI) approaches. These innovative approaches, supported by the availability of big data and large volumes of digital medical datasets, hold promise in better understanding the natural histories, predictors of disease development, severity, complications and treatment outcomes in complex diseases, providing decision support to doctors, and promising to bring us closer to the realization of the “precision medicine” paradigm. This review aims to provide an overview of current IBD omics based on both individual (genomics, transcriptomics, proteomics, metagenomics) and multi‐omics levels, highlighting how AI can facilitate the integration of heterogeneous data to summarize our current understanding of the disease and to identify current gaps in knowledge to inform upcoming research in this field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceInflammatory Bowel DiseasesMetagenomicsProteomicsHumansColitis, UlcerativeCrohn DiseaseGastrointestinal MicrobiomePrecision MedicineTranscriptomeMultiomics

Stichwörter der Autor:innen

Crohn's diseaseartificial intelligencedeep learninggenesgeneticsinflammatory bowel diseasemachine learningomicspathogenesisulcerative colitis

Autor:innen und Institutionen

  • Division of Gastroenterology and Endoscopy, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Gastroenterology and Digestive Endoscopy Department, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Innovation & Research Unit, Fondazione IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.
  • Gastroenterology and Digestive Endoscopy, San Camillo-Forlanini Hospital, Rome, Italy.
  • Faculty of Medicine, Università Vita-Salute San Raffaele, Milan, Italy.

ORCID-Profile: Anna Latiano, Matteo Riva, Federica Ungaro, Sonia Carparelli, Gionata Fiorino, Orazio Palmieri

Förderung

  • Italian Next Generation Eu Program

Zitieren

APA

Cannarozzi, A. L., Latiano, A., Massimino, L., Bossa, F., Giuliani, F., Riva, M., Ungaro, F., Guerra, M., Brina, A. L. D., Biscaglia, G., Tavano, F., Carparelli, S., Fiorino, G., Danese, S., Perri, F., & Palmieri, O. (2024). Inflammatory bowel disease genomics, transcriptomics, proteomics and metagenomics meet artificial intelligence. United European Gastroenterology Journal, 12(10), 1461-1480. https://doi.org/10.1002/ueg2.12655

Vancouver

Cannarozzi AL, Latiano A, Massimino L, Bossa F, Giuliani F, Riva M, et al. Inflammatory bowel disease genomics, transcriptomics, proteomics and metagenomics meet artificial intelligence. United European Gastroenterology Journal. 2024;12(10):1461-1480. doi:10.1002/ueg2.12655

BibTeX
@article{Cannarozzi2024,
  author = {Cannarozzi, Anna Lucia and Latiano, Anna and Massimino, Luca and Bossa, Fabrizio and Giuliani, Francesco and Riva, Matteo and Ungaro, Federica and Guerra, Maria and Brina, Anna Laura Di and Biscaglia, Giuseppe and Tavano, Francesca and Carparelli, Sonia and Fiorino, Gionata and Danese, Silvio and Perri, Francesco and Palmieri, Orazio},
  title = {Inflammatory bowel disease genomics, transcriptomics, proteomics and metagenomics meet artificial intelligence},
  journal = {United European Gastroenterology Journal},
  year = {2024},
  volume = {12},
  number = {10},
  pages = {1461--1480},
  doi = {10.1002/ueg2.12655}
}
Kostenlos starten →